Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography

Since the first report of the use of ultrasound for cardiovascular diagnosis by Edler and Hertz in 1954, echocardiography has expanded exponentially over the ensuing decades. The history of echocardiography is one of continuous innovation. With each discovery of new technology, the echocardiographic examination has progressively become longer, more comprehensive, and integrated with more diverse technology. In some circumstances, refined technology has completely replaced old methods. In other circumstances, new technology is incorporated to enhance existing capabilities. The purposes of this document are to (1) establish the content of a comprehensive TTE examination, (2) provide recommendations for technical performance and appropriate use of instrumentation during the examination, (3) provide guidance for the integration of the various ultrasound-based imaging modalities into the comprehensive examination, and (4) describe best practices for the measurement and display of the data generated by the comprehensive examination. It should be noted that pathology specific measurements are beyond the scope of this document.

Published Date

January 1, 2019

Source

JASE

Topic

  • Guidelines

Language

  • Chinese
  • English
  • Portuguese
  • Vietnamese

Technique

  • 3D Echocardiography (3DE)
  • Agitated Saline
  • Contrast
  • Ejection Fraction (EF)
  • Global Longitudinal Strain (GLS)
  • Left Ventricular Cavity Opacification (LVO)
  • Pulsed Echo Doppler Flow (PEDOF)
  • Right Ventricular Systolic Pressure (RVSP)
  • Strain
  • Tissue Doppler Imaging (TDI)
  • Transthoracic Echo (TTE)
  • Ultrasound Enhancing Agent

Disease

  • Amyloidosis
  • Aortic Regurgitation (AR)
  • Aortic Stenosis (AS)
  • Arrhythmogenic Right Ventricular Dysplasia
  • Cancer
  • Cardio-Oncology
  • Cardiomyopathy (CM)
  • Cardiovascular Disease (CVD)
  • Chagas Disease
  • Coronary Artery Disease (CAD)
  • Heart Failure (HF)
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
  • Heart Failure with Reduced Ejection Fraction (HFrEF)
  • Hypertrophic Cardiomyopathy (HCM)
  • Hypertrophic Obstructive Cardiomyopathy (HOCM)
  • Left Ventricular Hypertrophy (LVH)
  • Left Ventricular Outflow Tract ( LVOT)
  • Mitral Regurgitation (MR)
  • Mitral Stenosis (MS)
  • Myocardial Infarction (MI)
  • Non-Ischemic Heart Disease
  • Nonvalvular Heart Disease
  • Pulmonary Arterial Hypertension (PAH)
  • Restrictive Cardiomyopathy (RCM)
  • Rheumatic Heart Disease (RHD)
  • Right Ventricular Outflow Tract (RVOT)
  • Structural Heart Disease (SHD)
  • Tricuspid Regurgitation (TR)
  • Valvular Heart Disease (VHD)

Anatomy

  • Aortic Valve (AV)
  • Atrioventricular (AV)
  • Left Atrial Appendage (LAA)
  • Left Atrium (LA)
  • Left Ventricle or Left Ventricular (LV)
  • Left Ventricular Function (LVF)
  • Mitral Valve (MV)
  • Pulmonary Artery (PA)
  • Right Ventricle or Right Ventricular (RV)
  • Tricuspid Valve (TV)

Audience

  • Advanced Practice Practitioners
  • Allied Health
  • Fellows in Training
  • Medical Students
  • Nurse Practitioners
  • Physician Assistants
  • Physicians
  • Sonographer Students
  • Sonographers

2 MB

2 MB

4 MB

6 MB